Trial Profile
Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on macular edema secondary to branch retinal vein occlusion
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 May 2017
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Triamcinolone (Primary)
- Indications Retinal oedema; Retinal vein occlusion
- Focus Therapeutic Use
- 31 May 2016 New trial record